Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections
The pipeline for new antibiotics is dry. Despite the creation of public/private initiatives like Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (Carb-X) and the Antimicrobial Resistance (AMR) Centre, the current focus on ‘push-pull’ incentives for the pharmaceutical industry s...
| Main Authors: | , , |
|---|---|
| Format: | Record |
| Language: | English |
| Published: |
F1000Research
2019
|